{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:39:46Z","timestamp":1771670386215,"version":"3.50.1"},"reference-count":29,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2022,3,30]]},"DOI":"10.1536\/ihj.21-543","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:23:42Z","timestamp":1648592622000},"page":"398-403","source":"Crossref","is-referenced-by-count":2,"title":["Oral Adrenergic Agents Produced Ventricular Fibrillation and QT Prolongation in an Elderly Patient Carrying an &lt;i&gt;RYR2&lt;\/i&gt; Variant"],"prefix":"10.1536","volume":"63","author":[{"given":"Kanae","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingshan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Makiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Horie","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Uzui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jiang D, Chen W, Wang R, Zhang L, Chen SR. Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death. Proc Natl Acad Sci USA 2007; 104: 18309-14.","DOI":"10.1073\/pnas.0706573104"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995; 91: 1512-9.","DOI":"10.1161\/01.CIR.91.5.1512"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Saito A, Ohno S, Nuruki N, Nomura Y, Horie M, Yoshinaga M. Three cases of catecholaminergic polymorphic ventricular tachycardia with prolonged QT intervals including two cases of compound mutations. J Arrhythm 2018; 34: 291-3.","DOI":"10.1002\/joa3.12053"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Itoh H, Crotti L, Aiba T, <i>et al<\/i>. The genetics underlying acquired long QT syndrome: impact for genetic screening. Eur Heart J 2016; 37: 1456-64.","DOI":"10.1093\/eurheartj\/ehv695"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Karczewski KJ, Francioli LC, Tiao G, <i>et al<\/i>. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020; 581: 434-43.","DOI":"10.1530\/ey.17.14.3"},{"key":"6","unstructured":"6. 1000 Genomes. Available at: https:\/\/www.internationalgenome.org. Accessed February, 2022."},{"key":"7","unstructured":"7. TogoVar A comprehensive Japanese genetic variation database. Available at: https:\/\/togovar.biosciencedbc.jp\/. Accessed February, 2022."},{"key":"8","unstructured":"8. SNPs&amp;Go Predicting Human Disease-related Mutations in Proteins with Functional Annotations. Available at: http:\/\/snps-and-go.biocomp.unibo.it\/snps-and-go. Accessed February, 2022."},{"key":"9","unstructured":"9. MutationTester. Available at: http:\/\/www.mutationtaster.org. Accessed February, 2022."},{"key":"10","unstructured":"10. PolyPhen-2 prediction of functional effects of human nsSNPs. Available at: http:\/\/genetics.bwh.harvard.edu\/pph2. Accessed February, 2022."},{"key":"11","unstructured":"11. PROVEAN. Available at: http:\/\/sift.jcvi.org. Accessed February, 2022."},{"key":"12","unstructured":"12. CADD - Combined Annotation Dependent Depletion. Available at: http:\/\/cadd.gs.washington.edu. Accessed February, 2022."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Peng W, Shen H, Wu J, <i>et al<\/i>. Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2. Science 2016; 354: aah5324.","DOI":"10.1126\/science.aah5324"},{"key":"14","unstructured":"14. RCSB PDB. 5GO9: Cryo-EM structure of RyR2 in closed state. Available at: https:\/\/www.rcsb.org\/structure\/5GO9. Accessed February, 2022."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Tester DJ, Kopplin LJ, Will ML, Ackerman MJ. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005; 2: 1099-105.","DOI":"10.1016\/j.hrthm.2005.07.012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kauferstein S, Kiehne N, Erkapic D, <i>et al<\/i>. A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS. Int J Cardiol 2011; 146: 249-50.","DOI":"10.1016\/j.ijcard.2010.10.062"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tanaka Y, Kawabata M, Scheinman MM, Hirao K. Catecholaminergic Polymorphic Ventricular Tachycardia with QT Prolongation. Pacing Clin Electrophysiol 2015; 38: 1499-502.","DOI":"10.1111\/pace.12735"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Arakawa J, Hamabe A, Aiba T, <i>et al<\/i>. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia. Heart Vessels 2015; 30 (6): 835-40.","DOI":"10.1007\/s00380-014-0555-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Taniguchi Y, Miyazaki A, Sakaguchi H, <i>et al<\/i>. Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene. Heart Vessels 2017; 32: 229-33.","DOI":"10.1007\/s00380-016-0869-z"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Sy RW, Gollob MH, Klein GJ, <i>et al<\/i>. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2011; 8: 864-71.","DOI":"10.1016\/j.hrthm.2011.01.048"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vink AS, Clur SB, Wilde AAM, Blom NA. Effect of age and gender on the QTc-interval in healthy individuals and patients with long-QT syndrome. Trends Cardiovasc Med 2018; 28: 64-75.","DOI":"10.1016\/j.tcm.2017.07.012"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: 327-9.","DOI":"10.1016\/S0140-6736(94)91164-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Richards S, Aziz N, Bale S, <i>et al<\/i>; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-24.","DOI":"10.1038\/gim.2015.30"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Chi X, Gong D, Ren K, <i>et al<\/i>. Molecular basis for allosteric regulation of the type 2 ryanodine receptor channel gating by key modulators. Proc Natl Acad Sci USA 2019; 116: 25575-82.","DOI":"10.1073\/pnas.1914451116"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Shakur Y, Fong M, Hensley J, <i>et al<\/i>. Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart. Cardiovasc Drugs Ther 2002; 16: 417-27.","DOI":"10.1023\/A:1022186402442"},{"key":"26","unstructured":"26.  Available at: https:\/\/www.crediblemeds.org."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ramezany Yasuj S, Nourhashemi M, Keshavarzi S, Motaghinejad M, Motevalian M. Possible role of cyclic AMP response element binding\/brain-derived neurotrophic factor signaling pathway in mediating the pharmacological effects of duloxetine against methamphetamine use-induced cognitive impairment and withdrawal-induced anxiety and depression in rats. Adv Biomed Res 2019; 8: 11.","DOI":"10.4103\/abr.abr_34_18"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Bers DM. Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205.","DOI":"10.1038\/415198a"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. \u0160tuhec M. Duloxetine-induced life-threatening long QT syndrome. Wien Klin Wochenschr 2013; 125: 165-6.","DOI":"10.1007\/s00508-013-0330-6"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/2\/63_21-543\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:46:24Z","timestamp":1648874784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/2\/63_21-543\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-543","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"article-number":"21-543"}}